Format
Sealed research vial
Trust signal
COA-backed inventory
99%+ Purity
Lab-grade supply. Limited AU stock. Note: currently ships without label.
From A$149
Select options below
Size
Select one
Select your preferred options to continue.
Fast AU dispatch, tracked delivery, and documentation-ready inventory.
Why labs buy from APL
High purity, consistent supply, and fast AU-wide dispatch.
Certificate of Analysis
Certificate of Analysis
Verified purity: Available in document
NAD+
From A$149
NAD+ is a catalogued research peptide or laboratory reference material with a defined primary sequence and analytical identity.
For laboratory teams, practical emphasis falls on identity confirmation by mass spectrometry or HPLC, comparator selection within the relevant peptide class, and reproducible handling practices. Cross-referencing with adjacent catalogue entries that share receptor family membership or structural class helps build a coherent assay panel.
Browse Inventory
In research literature, NAD+ is generally treated as a catalogued research peptide or laboratory reference material with a defined primary sequence and analytical identity. Published discussion around this class typically centres on sequence-specific receptor or enzyme interactions characterised under in vitro conditions, downstream signalling pathway readouts, and how structural features — amino acid composition, chain length, terminal modifications, or cyclisation — influence assay persistence and analytical stability. The specific receptor target and signalling mechanism should be verified from current literature before designing experiments.
For laboratory teams, practical emphasis falls on identity confirmation by mass spectrometry or HPLC, comparator selection within the relevant peptide class, and reproducible handling practices. Cross-referencing with adjacent catalogue entries that share receptor family membership or structural class helps build a coherent assay panel. For laboratory teams, the practical emphasis is usually on sequence identity, receptor or pathway relevance where documented, and whether NAD+ behaves consistently across stability, purity, and analytical verification workflows. Variant labels on this page support clearer internal referencing when multiple labelled variants are under review.
Potential research applications for NAD+ should be framed strictly in analytical and laboratory terms. Typical reasons a team might review this product page include:
Handling decisions should always follow the vial label, internal SOPs, and any product-specific documentation. A conservative laboratory baseline for NAD+ is:
A product-specific COA is linked on this page, with purity noted as available in the document. The COA section is useful for confirming how the product is labelled in the catalogue, whether purity information has been published, and whether the laboratory record for the material is complete before bench use.
When teams compare NAD+ with Retatrutide, CJC (NO DAC) + IPA, and Tesamorelin, COA access also helps keep comparator decisions grounded in documented material identity rather than assumption. That is especially important for research pages that combine pricing, variant selection, and analytical records on a single URL.
Certificate of Analysis
Certificate of Analysis
Verified purity: Available in document
It brings together 2 labelled variants: 500mg and 1000mg, current pricing context, stock visibility, COA access, and internal links to related catalogue pages so a laboratory buyer can review the material from a single reference URL.
NAD+ is generally discussed as a catalogued research peptide or laboratory reference material with a defined primary sequence and analytical identity. The most relevant background is sequence behaviour, pathway or receptor context where documented, and analytical consistency under controlled laboratory conditions.
Use the label, COA, and internal SOPs as the primary guide. In general, store the material under controlled laboratory conditions, minimise avoidable environmental exposure, and keep variant tracking records current.
Yes. This listing includes access to a product-specific COA, which should be reviewed before use so purity, identity, and documentation checks are aligned with the project record.
No. The page should be interpreted strictly in a research and laboratory context. It does not provide dosage guidance, treatment claims, or human or animal use instructions.
